West Pharmaceutical Services Inc(WST)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

WST West Pharmaceutical Services Inc

休市中 06-26 16:00:00 EDT

350.85

+4.29

+1.24%

盘后350.85

+0.000.00%

19:05 EDT

最高351.35	最低342.70	成交量125.50万
今开345.36	昨收346.56	日振幅2.50%
总市值247.87亿	流通市值246.08亿	总股本7,065万
成交额4.38亿	换手率1.79%	流通股本7,014万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"WST","market":"US","secType":"STK","nameCN":"West Pharmaceutical Services Inc","latestPrice":350.85,"timestamp":1782504000000,"preClose":346.56,"halted":0,"volume":1254978,"hourTrading":{"tag":"盘后","latestPrice":350.85,"preClose":350.85,"latestTime":"19:05 EDT","volume":159681,"amount":56024070.59228,"timestamp":1782515116343,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.012378808864265987,"floatShares":70139300,"shares":70647595,"eps":7.482439,"marketStatus":"休市中","change":4.29,"latestTime":"06-26 16:00:00 EDT","open":345.36,"high":351.35,"low":342.7001,"amount":437696819.69256,"amplitude":0.024959,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":7.482439,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1782720000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":391752000000,"exchange":"NYSE","adjPreClose":346.56,"dividendRate":0.002451,"preHourTrading":{"tag":"盘前","latestPrice":346.56,"preClose":346.25,"latestTime":"07:42 EDT","volume":7,"amount":2447.80501,"timestamp":1782474148203,"change":0.31,"changeRate":0.000895,"amplitude":0.020116},"postHourTrading":{"tag":"盘后","latestPrice":350.85,"preClose":350.85,"latestTime":"19:05 EDT","volume":159681,"amount":56024070.59228,"timestamp":1782515116343,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1215621284924815,"impliedVol":0.39,"impliedVolPercentile":0.6096},"requestUrl":"/m/hq/s/WST/tweets","defaultTab":"tweets","newsList":[{"id":"1187679080","title":"巴克莱将West Pharmaceutical Services Inc评级上调至超配，目标价提至400美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1187679080","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187679080?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:22","pubTimestamp":1781086936,"startTime":"0","endTime":"0","summary":"巴克莱银行将West Pharmaceutical Services Inc的股票评级从“均配”上调至“超配”，同时将其目标股价从310美元大幅提升至400美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","LU0106261612.USD","LU0345774631.USD","BK4504","BK4588","IE00B64QTZ34.USD","IE00BFXG0V08.USD","BK4121","LU0012050646.USD","BK4585","LU0345774391.USD","WST","IE00BYQQ9H92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133725685","title":"West Pharmaceutical Services核心企业系统已恢复 所有工厂在遭遇网络攻击后重启生产、收货与发货","url":"https://stock-news.laohu8.com/highlight/detail?id=1133725685","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133725685?lang=zh_cn&edition=full","pubTime":"2026-05-21 04:32","pubTimestamp":1779309134,"startTime":"0","endTime":"0","summary":"在经历网络攻击后，West Pharmaceutical Services Inc已成功恢复其核心企业系统的运行。目前，公司旗下所有工厂的生产、收货及发货业务均已全面重启。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345774631.USD","BK4504","BK4588","IE00BFXG0V08.USD","LU0106261612.USD","BK4585","BK4567","IE00BYQQ9H92.USD","IE00B64QTZ34.USD","LU0345774391.USD","LU0012050646.USD","BK4121","WST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137825018","title":"West Pharmaceutical旗下HVP站点、标准包装站点及HVP给药装置站点全面恢复收发货运营","url":"https://stock-news.laohu8.com/highlight/detail?id=1137825018","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137825018?lang=zh_cn&edition=full","pubTime":"2026-05-16 01:20","pubTimestamp":1778865620,"startTime":"0","endTime":"0","summary":"West Pharmaceutical Services Inc宣布，其高价值产品（HVP）站点、标准包装站点以及HVP给药装置站点现已全面恢复收发货运营。所有相关设施均已恢复正常运作，能够处理客户订单的接收与发运。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WST","BK4585","BK4588","LU0012050646.USD","LU0345774391.USD","BK4567","BK4504","IE00B64QTZ34.USD","LU0345774631.USD","IE00BFXG0V08.USD","LU0106261612.USD","BK4121","IE00BYQQ9H92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154399045","title":"West Pharmaceutical Services：多数West Vantage站点已投入运营，关键收发流程就绪，生产正加速推进","url":"https://stock-news.laohu8.com/highlight/detail?id=1154399045","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154399045?lang=zh_cn&edition=full","pubTime":"2026-05-16 01:17","pubTimestamp":1778865474,"startTime":"0","endTime":"0","summary":"West Pharmaceutical Services宣布，其大部分West Vantage站点现已投入运营，关键的发货与接收流程已准备就绪，同时生产活动正在加速推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WST","LU0345774631.USD","BK4504","BK4567","IE00BFXG0V08.USD","LU0106261612.USD","BK4585","LU0012050646.USD","BK4588","IE00BYQQ9H92.USD","BK4121","IE00B64QTZ34.USD","LU0345774391.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190535433","title":"West Pharmaceutical Services：全球业务恢复取得显著进展，网络攻击后运营逐步回归正轨","url":"https://stock-news.laohu8.com/highlight/detail?id=1190535433","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190535433?lang=zh_cn&edition=full","pubTime":"2026-05-16 01:16","pubTimestamp":1778865382,"startTime":"0","endTime":"0","summary":"West Pharmaceutical Services Inc 近日宣布，在应对全球范围内的网络攻击事件后，公司在恢复运营方面持续取得重大进展。目前，各项业务正稳步回归正轨，系统与服务的恢复工作正按计划推进。\n公司表示，其团队正全力以赴，以安全、可控的方式逐步重启全球运营。此次恢复进程涵盖了关键业务环节，旨在最小化对客户及合作伙伴的影响。\n尽管面临挑战，West Pharmaceutical Services 强调其致力于保障供应链的完整性与产品交付的可靠性。公司将继续向利益相关方通报最新情况，并采取一切必要措施强化其网络安全防护体系。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345774631.USD","BK4504","LU0345774391.USD","IE00BYQQ9H92.USD","LU0012050646.USD","LU0106261612.USD","BK4585","WST","BK4588","IE00B64QTZ34.USD","BK4121","IE00BFXG0V08.USD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158076896","title":"West Pharmaceutical高管称：通过缓解措施后，公司预计净影响为数百万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158076896","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158076896?lang=zh_cn&edition=full","pubTime":"2026-04-23 20:23","pubTimestamp":1776947024,"startTime":"0","endTime":"0","summary":"在电话会议中，West Pharmaceutical Services Inc的一位高管表示，公司预计在采取缓解措施后，净财务影响将控制在数百万美元的单位数范围内。\n这一表态揭示了公司对潜在财务影响的评估，显示出经过风险管控后，最终影响相对有限。数百万美元的单位数规模表明，公司已通过有效的应对策略将可能的损失降至可控水平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WST","IE00BYQQ9H92.USD","LU0345774631.USD","IE00BFXG0V08.USD","BK4504","BK4121","BK4588","LU0106261612.USD","LU0012050646.USD","IE00B64QTZ34.USD","BK4585","BK4567","LU0345774391.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116057865","title":"West Pharmaceutical高管称公司已将油价及大宗商品涨价纳入更新版业绩指引 并采取措施抵消成本上升影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1116057865","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116057865?lang=zh_cn&edition=full","pubTime":"2026-04-23 20:23","pubTimestamp":1776946995,"startTime":"0","endTime":"0","summary":"在电话会议中，West Pharmaceutical Services Inc高管表示，公司已在最新发布的业绩展望中充分考虑了原油及大宗商品价格持续上涨的影响。\n该高管进一步指出，为应对原材料成本上升带来的压力，公司已积极采取多项针对性措施，旨在有效抵消这部分增加的成本支出。这些举措将有助于维持公司的利润水平，确保财务目标的实现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0012050646.USD","WST","IE00B64QTZ34.USD","BK4567","BK4121","LU0106261612.USD","LU0345774631.USD","BK4504","BK4585","LU0345774391.USD","IE00BYQQ9H92.USD","IE00BFXG0V08.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197130045","title":"异动解读 | West Pharmaceutical盘前大涨9.33%，一季度业绩超预期并上调展望","url":"https://stock-news.laohu8.com/highlight/detail?id=1197130045","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197130045?lang=zh_cn&edition=full","pubTime":"2026-04-23 19:02","pubTimestamp":1776942178,"startTime":"0","endTime":"0","summary":"West Pharmaceutical Services Inc（WST）今日盘前股价大幅上涨9.33%，引起了市场的广泛关注。消息面上，公司发布的一季度财报显示，各项核心数据均大幅超出市场预期。一季度营收达8.449亿美元，同比增长21.0%；非GAAP每股收益为2.13美元，超出预期0.45美元。此外，公司还同步上调了全年及二季度的业绩展望，增强了投资者信心。同时，公司宣布自2026年第一季度起，将“合同制造产品”报告分部更名为“West Vantage”，这一品牌重塑举措也体现了公司对该业务板块未来发展的战略定位，可能进一步提振了市场情绪。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["WST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629838829","title":"West Pharmaceutical(WST)涨超10% 一季度业绩大幅超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2629838829","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629838829?lang=zh_cn&edition=full","pubTime":"2026-04-23 18:33","pubTimestamp":1776940413,"startTime":"0","endTime":"0","summary":"金吾财讯 | West Pharmaceutical 盘前股价大幅上扬，报303.37美元，涨10.55%。消息面上，West Pharmaceutical发布一季度财报，各项核心数据均大幅超出市场预期。一季度公司营收8.449亿美元，同比增长21.0%；非GAAP每股收益2.13美元，超出预期0.45美元。公司当期完成股票回购，以均价243.57美元累计回购120万股，耗资2.976亿美元。公司同步上调全年及二季度业绩展望。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/NDViNTE0MThlOGIzNGVjYjVmZmFmNTJlOTIxNzAyOTY1ODYyNw==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NDViNTE0MThlOGIzNGVjYjVmZmFmNTJlOTIxNzAyOTY1ODYyNw==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"299606","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFXG0V08.USD","IE00BYQQ9H92.USD","BK4121","LU0345774391.USD","WST","BK4567","BK4585","BK4588","LU0012050646.USD","LU0345774631.USD","IE00B64QTZ34.USD","BK4504","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153793733","title":"West Pharmaceutical Services Inc 2026年第一季度起将\"合同制造产品\"报告分部更名为\"West Vantage\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1153793733","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153793733?lang=zh_cn&edition=full","pubTime":"2026-04-23 18:03","pubTimestamp":1776938594,"startTime":"0","endTime":"0","summary":"West Pharmaceutical Services Inc宣布，自2026年第一季度起，公司将正式把\"合同制造产品\"报告分部更名为\"West Vantage\"。这一战略性的品牌重塑举措，标志着公司对该业务板块未来发展定位的重新定义。\n此次名称变更不仅体现了West Pharmaceutical对合同制造业务价值链的优化升级，更凸显了企业致力于通过\"West Vantage\"这一新品牌为客户提供更高效、更创新解决方案的承诺。新名称传递出公司希望成为合作伙伴战略优势来源的愿景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345774631.USD","BK4588","LU0012050646.USD","IE00BFXG0V08.USD","LU0106261612.USD","BK4121","WST","IE00B64QTZ34.USD","LU0345774391.USD","BK4567","BK4504","IE00BYQQ9H92.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618268967","title":"West Pharmaceutical Services, Inc.盘中异动 早盘大幅跳水5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618268967","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618268967?lang=zh_cn&edition=full","pubTime":"2026-03-10 21:33","pubTimestamp":1773149631,"startTime":"0","endTime":"0","summary":"北京时间2026年03月10日21时33分，West Pharmaceutical Services, Inc.股票出现波动，股价急速下跌5.58%。West Pharmaceutical Services, Inc.股票所在的医疗设备行业中，整体涨幅为0.00%。其相关个股中，Anbio Biotechnology、哈佛生物科学、Microbot Medical Inc.涨幅较大，Nexgel, Inc、Microbot Medical Inc.、Ekso Bionics Holdings, Inc.较为活跃，换手率分别为49.76%、0.28%、0.17%，振幅较大的相关个股有Zentek Ltd.、中进医疗、Stereotaxis, Inc.，振幅分别为9.05%、6.46%、4.83%。West Pharmaceutical Services, Inc.公司简介：西氏医药服务公司总部位于宾夕法尼亚州，是制药、生物技术和仿制药行业公司的主要供应商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031021335197ac196e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031021335197ac196e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0345774631.USD","BK4585","IE00B64QTZ34.USD","BK4121","LU0345774391.USD","WST","IE00BYQQ9H92.USD","BK4567","LU0012050646.USD","IE00BFXG0V08.USD","BK4588","LU0106261612.USD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183513309","title":"Eric M. Green 宣布将卸任 West Pharmaceutical Services, Inc. 总裁、CEO及董事会主席职务","url":"https://stock-news.laohu8.com/highlight/detail?id=1183513309","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183513309?lang=zh_cn&edition=full","pubTime":"2026-03-10 04:31","pubTimestamp":1773088284,"startTime":"0","endTime":"0","summary":"Eric M. Green 已向董事会通报其退休计划，将辞去 West Pharmaceutical Services, Inc. 的总裁、首席执行官以及董事会主席的职位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0012050646.USD","IE00B64QTZ34.USD","IE00BFXG0V08.USD","BK4121","LU0345774631.USD","LU0106261612.USD","IE00BYQQ9H92.USD","BK4588","BK4585","LU0345774391.USD","WST","BK4567","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186611264","title":"异动解读 | 西氏医药盘中大跌5.02%，市场担忧GLP-1药物需求增速放缓","url":"https://stock-news.laohu8.com/highlight/detail?id=1186611264","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186611264?lang=zh_cn&edition=full","pubTime":"2026-02-13 01:22","pubTimestamp":1770916931,"startTime":"0","endTime":"0","summary":"西氏医药服务公司今日盘中股价大跌5.02%，引起了市场关注。消息面上，公司虽然预测2026年调整后每股利润将高于华尔街预期，但其高管在电话会议中指出，用于糖尿病和肥胖症治疗的GLP-1类药物需求在2026年的增长节奏将比2025年“放缓”。尽管公司第四季度业绩及年度利润指引均超出预期，但市场焦点似乎转向了对主力产品需求增速可能见顶以及长期增长门槛较高的疑虑上。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["WST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189264003","title":"西氏医药高管：GLP-1药物采用率需超30%方能实现公司10%同比增速","url":"https://stock-news.laohu8.com/highlight/detail?id=1189264003","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189264003?lang=zh_cn&edition=full","pubTime":"2026-02-12 21:39","pubTimestamp":1770903556,"startTime":"0","endTime":"0","summary":"在最新电话会议中，西氏医药服务公司高管指出，若要推动公司年同比增长率达到10%，GLP-1类药物的市场渗透率必须突破30%的关键阈值。这一表态凸显了新型代谢疗法对医疗供应链企业的业绩拉动作用，也反映出制药行业技术变革对上下游产业的深远影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","BK4567","LU0345774391.USD","BK4121","LU0345774631.USD","IE00BFXG0V08.USD","IE00B64QTZ34.USD","WST","BK4585","IE00BYQQ9H92.USD","LU0012050646.USD","LU0106261612.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132302810","title":"West Pharma高管称客户行为未现变化 年度预测为保守起点-电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1132302810","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132302810?lang=zh_cn&edition=full","pubTime":"2026-02-12 21:36","pubTimestamp":1770903388,"startTime":"0","endTime":"0","summary":"在最新电话会议中，West Pharmaceutical Services Inc高管表示，目前未观察到客户行为出现显著变化。公司将其年度财务预测描述为\"保守的起点\"，强调这一规划基于当前市场环境的审慎评估。管理层指出，尽管全球经济存在不确定性，但主营业务需求保持稳定，对实现全年目标持谨慎乐观态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64QTZ34.USD","LU0345774631.USD","BK4585","WST","BK4588","LU0345774391.USD","BK4567","LU0012050646.USD","IE00BFXG0V08.USD","BK4504","LU0106261612.USD","IE00BYQQ9H92.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149286797","title":"West Pharma高管：GLP-1需求预计2026年继续增长，但增速将低于2025年","url":"https://stock-news.laohu8.com/highlight/detail?id=1149286797","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149286797?lang=zh_cn&edition=full","pubTime":"2026-02-12 21:26","pubTimestamp":1770902776,"startTime":"0","endTime":"0","summary":"在最新电话会议中，West Pharmaceutical Services Inc高管指出，尽管GLP-1类药物需求在2025年呈现强劲增势，但预计2026年增长节奏将有所放缓。该预测反映了市场对这类代谢疾病治疗药物长期需求曲线的专业判断，同时暗示行业可能进入阶段性调整期。值得注意的是，增速回落并非需求萎缩，而是市场基数扩大后的自然演化，全球糖尿病与肥胖症治疗领域的底层需求依然坚实。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64QTZ34.USD","LU0012050646.USD","LU0345774631.USD","LU0106261612.USD","LU0345774391.USD","BK4567","IE00BYQQ9H92.USD","WST","IE00BFXG0V08.USD","BK4585","BK4504","BK4588","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146290440","title":"West Pharma高管重申：预计2026年GLP-1注射与口服剂型将持续增长——电话会议透露","url":"https://stock-news.laohu8.com/highlight/detail?id=1146290440","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146290440?lang=zh_cn&edition=full","pubTime":"2026-02-12 21:17","pubTimestamp":1770902235,"startTime":"0","endTime":"0","summary":"在最新电话会议中，West Pharmaceutical高管明确表示，公司对2026年GLP-1类药物市场前景保持乐观。无论是注射剂型还是口服剂型，均被预期为驱动业务增长的双引擎。这一表态凸显了企业对该细分领域长期需求的信心，同时也反映出制药行业技术路线多元化的趋势正在加速渗透。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","IE00BFXG0V08.USD","LU0012050646.USD","LU0106261612.USD","BK4504","WST","BK4567","BK4585","LU0345774631.USD","LU0345774391.USD","BK4588","IE00BYQQ9H92.USD","IE00B64QTZ34.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162396907","title":"West Pharma高管预计2026年将呈现\"广泛增长态势\"，非GLP-1高价值部件驱动中低个位数增长——电话会议实录","url":"https://stock-news.laohu8.com/highlight/detail?id=1162396907","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162396907?lang=zh_cn&edition=full","pubTime":"2026-02-12 21:13","pubTimestamp":1770901997,"startTime":"0","endTime":"0","summary":"在最新电话会议中，West Pharmaceutical高管层透露，公司对2026年业绩展望持乐观态度，预计将形成\"全面增长格局\"。这一增长动能主要来源于非GLP-1高价值产品组合的持续发力，其增速预计将维持在中等至较低个位数区间。值得注意的是，管理层特别强调非GLP-1业务线的稳健性。虽然当前市场焦点集中于GLP-1相关领域，但公司传统高价值部件展现出的韧性将成为未来增长的重要支柱。通过精准的产品组合策略与技术创新，West Pharmaceutical正逐步构建跨越不同医疗领域的增长引擎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WST","IE00BYQQ9H92.USD","LU0345774631.USD","IE00BFXG0V08.USD","BK4504","BK4121","BK4588","LU0106261612.USD","LU0012050646.USD","IE00B64QTZ34.USD","BK4585","BK4567","LU0345774391.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603796764","title":"2026斯诺克世界大奖赛携全新赛制即将香港开赛","url":"https://stock-news.laohu8.com/highlight/detail?id=2603796764","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603796764?lang=zh_cn&edition=full","pubTime":"2026-01-16 18:49","pubTimestamp":1768560540,"startTime":"0","endTime":"0","summary":"今年2月，斯诺克世界的目光将再度聚焦东方之珠。2026年2月3日至8日，世界斯诺克巡回赛排名赛——斯诺克世界大奖赛2026将在中国香港启德体育园回归。令人振奋的是，中国选手在本赛季表现强势，共有10人成功锁定席位，刷新该赛事中国军团参赛人数纪录。为了提升赛事的公平性与观赏性，2026年世界大奖赛赛制迎来重要革新，赛事落户香港后，比赛影响力不断上涨。敬请关注“2026斯诺克世界大奖赛”官方赛事信息，获取最新动态与购票信息。","market":"hk","thumbnail":"https://media.bjnews.com.cn/image/2026/01/16/5676284735010185713.png?x-oss-process=image/resize,m_lfit,w_365","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/image/2026/01/16/5676284735010185713.png?x-oss-process=image/resize,m_lfit,w_365"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1768555955129573.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1768555955129573.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["WST","BK4585","BK4588","LU0012050646.USD","LU0345774391.USD","BK4567","BK4504","IE00B64QTZ34.USD","LU0345774631.USD","IE00BFXG0V08.USD","LU0106261612.USD","BK4121","IE00BYQQ9H92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140361953","title":"艾伯维收购亚利桑那州生产设施，持续强化美国本土制造能力","url":"https://stock-news.laohu8.com/highlight/detail?id=1140361953","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140361953?lang=zh_cn&edition=full","pubTime":"2026-01-12 19:01","pubTimestamp":1768215713,"startTime":"0","endTime":"0","summary":"艾伯维公司近日宣布，将收购位于亚利桑那州的一处生产设施。这一战略举措旨在进一步增强其在美国本土的制造实力，为未来的产品供应提供有力保障。收购完成后，该设施将整合进艾伯维现有的生产网络，提升其在关键治疗领域的产能与灵活性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","IE00BDGV0183.EUR","SG9999015986.USD","LU2089283258.USD","BK4533","IE0009355771.USD","LU2133065610.SGD","LU1551013342.USD","LU0882574055.USD","LU0456855351.SGD","BK4559","LU0122379950.USD","LU0689626769.HKD","IE00B42XCP33.USD","LU2468319806.SGD","LU0345774631.USD","LU1061106388.HKD","LU1732800096.USD","LU0795875169.SGD","LU0553294199.USD","LU0708994859.HKD","LU2237443465.HKD","LU0289739699.SGD","LU0128525929.USD","LU0689472784.USD","LU0545039389.USD","LU2347655156.SGD","LU1037948897.HKD","IE00BGHQF631.EUR","LU1074936037.SGD","BK4581","IE0004445239.USD","LU0203347892.USD","LU0820561818.USD","IE00B3PB1722.GBP","LU0198837287.USD","WST","LU0211327993.USD","LU0211328371.USD","LU1057294990.SGD","LU1267930573.SGD","IE00BBT3K403.USD","ABBV","LU0310799852.SGD","BK4139","SG9999015952.SGD","SG9999001440.SGD","LU2129689514.USD","IE00B4R5TH58.HKD","LU2237443549.SGD","LU0912757837.SGD","IE00BSNM7G36.USD","BK4585","LU1496350502.SGD","LU1718418525.SGD","SG9999003800.SGD","LU0310800379.SGD","IE00BYQQ9H92.USD","LU0234572021.USD","BK4567","LU0058720904.USD","LU0661504455.SGD","LU0203345920.USD","IE0002141913.USD","IE0002270589.USD","LU1430594728.SGD","LU1585245621.USD","SG9999015945.SGD","BK4566","LU2129689605.HKD","LU1093756325.SGD","LU0098860793.USD","LU0158827948.USD","LU2089984988.USD","LU0432979614.USD","IE00B19Z3581.USD","LU0417517546.SGD","LU1244550577.SGD","LU1989771016.USD","IE00BN8TJ469.HKD","LU1267930490.SGD","IE00B19Z3B42.SGD","LU0965509283.SGD","BK4588","LU0949170772.SGD","IE00B64QTZ34.USD","BK4504","LU2237443382.USD","LU1934455277.USD","IE00BFXG0V08.USD","LU0124676726.USD","LU0943347566.SGD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0985320562.USD","LU1934455194.USD","LU0029864427.USD","LU0106261612.USD","LU0234570918.USD","LU2023251221.USD","LU0965508806.USD","IE00BJJMRZ35.SGD","LU0012050646.USD","LU1983299246.USD","LU0795875086.SGD","SG9999011175.SGD","LU0345774391.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","SG9999015978.USD","LU1934455863.HKD","LU2237443978.SGD","LU1989772840.SGD","IE00BVYPNW00.USD","LU1989772923.USD","LU1244550221.USD","LU2237443895.HKD","LU0256863902.USD","LU1839511570.USD","LU1291159041.SGD","LU0820561909.HKD","LU1037948541.HKD","LU0965509010.AUD","LU0114720955.EUR","LU1003077747.HKD","LU1093756168.USD","LU0738911758.USD","IE00B2B36J28.USD","LU0170899867.USD","LU1162221912.USD","LU1244550494.USD","LU0965509101.SGD","LU2237443622.USD","BK4550","LU1496350171.SGD","LU0256863811.USD","LU1732799900.SGD","LU0861579265.USD","BK4121","LU2089284900.SGD","LU1023059063.AUD","LU1551013425.SGD","LU2129689431.USD","IE00BVYPNV92.GBP","LU2087621335.USD","LU2112291526.USD","LU1929549753.HKD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.westpharma.com","stockEarnings":[{"period":"1week","weight":0.0698},{"period":"1month","weight":0.122},{"period":"3month","weight":0.4418},{"period":"6month","weight":0.2791},{"period":"1year","weight":0.6021},{"period":"ytd","weight":0.2752}],"compareEarnings":[{"period":"1week","weight":-0.0238},{"period":"1month","weight":-0.0286},{"period":"3month","weight":0.1497},{"period":"6month","weight":0.056},{"period":"1year","weight":0.1914},{"period":"ytd","weight":0.069}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"West Pharmaceutical Services, Inc.根据宾夕法尼亚州的法律于1923年7月27日成立。该公司是设计和生产技术先进，高质量，集成化的用于注射药物和保健产品的密封和输送系统的全球领先制造商。该公司的产品包括各种初级包装，容纳解决方案，重构和转移系统，药物输送系统，以及合同制造，分析实验室服务和集成解决方案。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.008018},{"month":2,"riseRate":0.543478,"avgChangeRate":0.003142},{"month":3,"riseRate":0.586957,"avgChangeRate":0.021659},{"month":4,"riseRate":0.595745,"avgChangeRate":0.040483},{"month":5,"riseRate":0.553191,"avgChangeRate":0.00339},{"month":6,"riseRate":0.574468,"avgChangeRate":0.019272},{"month":7,"riseRate":0.586957,"avgChangeRate":0.011963},{"month":8,"riseRate":0.608696,"avgChangeRate":0.008395},{"month":9,"riseRate":0.478261,"avgChangeRate":-0.00228},{"month":10,"riseRate":0.565217,"avgChangeRate":0.005454},{"month":11,"riseRate":0.695652,"avgChangeRate":0.016909},{"month":12,"riseRate":0.673913,"avgChangeRate":0.026146}],"exchange":"NYSE","name":"West Pharmaceutical Services Inc","nameEN":"West Pharmaceutical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"West Pharmaceutical Services Inc(WST)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供West Pharmaceutical Services Inc(WST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"West Pharmaceutical Services Inc,WST,West Pharmaceutical Services Inc股票,West Pharmaceutical Services Inc股票老虎,West Pharmaceutical Services Inc股票老虎国际,West Pharmaceutical Services Inc行情,West Pharmaceutical Services Inc股票行情,West Pharmaceutical Services Inc股价,West Pharmaceutical Services Inc股市,West Pharmaceutical Services Inc股票价格,West Pharmaceutical Services Inc股票交易,West Pharmaceutical Services Inc股票购买,West Pharmaceutical Services Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"West Pharmaceutical Services Inc(WST)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供West Pharmaceutical Services Inc(WST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}